175 related articles for article (PubMed ID: 27398812)
21. Diagnostic concordance of breast pathologists: lessons from the National Health Service Breast Screening Programme Pathology External Quality Assurance Scheme.
Rakha EA; Ahmed MA; Aleskandarany MA; Hodi Z; Lee AH; Pinder SE; Ellis IO
Histopathology; 2017 Mar; 70(4):632-642. PubMed ID: 28028831
[TBL] [Abstract][Full Text] [Related]
22. Borderline breast lesions: diagnostic challenges and clinical implications.
Masood S; Rosa M
Adv Anat Pathol; 2011 May; 18(3):190-8. PubMed ID: 21490436
[TBL] [Abstract][Full Text] [Related]
23. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
Piubello Q; Montemezzi S; D'Atri C
Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
[TBL] [Abstract][Full Text] [Related]
24. Atypical Ductal Lesions of the Breast: Criteria, Significance, and Laboratory Updates.
East EG; Carter CS; Kleer CG
Arch Pathol Lab Med; 2018 Oct; 142(10):1182-1185. PubMed ID: 30281370
[TBL] [Abstract][Full Text] [Related]
25. Observer variability in reporting of breast lesions.
Beck JS
J Clin Pathol; 1985 Dec; 38(12):1358-65. PubMed ID: 3001153
[TBL] [Abstract][Full Text] [Related]
26. [Diagnostic pitfalls in mammary pathology. Case 1. In situ ductal carcinoma of low nuclear grade, with papillary, micropapillary and cribriform architecture].
MacGrogan G
Ann Pathol; 2009 Jun; 29(3):188-93. PubMed ID: 19619824
[No Abstract] [Full Text] [Related]
27. Reproducibility of three classification systems of ductal carcinoma in situ of the breast using a web-based survey.
Schuh F; Biazús JV; Resetkova E; Benfica CZ; Edelweiss MI
Pathol Res Pract; 2010 Oct; 206(10):705-11. PubMed ID: 20663616
[TBL] [Abstract][Full Text] [Related]
28. Lobular neoplasia on core-needle biopsy--clinical significance.
Arpino G; Allred DC; Mohsin SK; Weiss HL; Conrow D; Elledge RM
Cancer; 2004 Jul; 101(2):242-50. PubMed ID: 15241819
[TBL] [Abstract][Full Text] [Related]
29. Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists.
Iczkowski KA; Egevad L; Ma J; Harding-Jackson N; Algaba F; Billis A; Camparo P; Cheng L; Clouston D; Comperat EM; Datta MW; Evans AG; Griffiths DF; Guo CC; Hailemariam S; Huang W; Humphrey PA; Jiang Z; Kahane H; Kristiansen G; La Rosa FG; Lopez-Beltran A; MacLennan GT; Magi-Galluzzi C; Merrimen J; Montironi R; Osunkoya AO; Picken MM; Rao N; Shah RB; Shanks JH; Shen SS; Tawfik OW; True LD; Van der Kwast T; Varma M; Wheeler TM; Zynger DL; Sahr N; Bostwick DG
Ann Diagn Pathol; 2014 Dec; 18(6):333-42. PubMed ID: 25263387
[TBL] [Abstract][Full Text] [Related]
30. The significance of extracellular mucin in breast fine needle aspiration specimens.
Shield PW; Ribu DL; Cominos D
Cytopathology; 2016 Jun; 27(3):185-92. PubMed ID: 26104545
[TBL] [Abstract][Full Text] [Related]
31. Computerized classification of intraductal breast lesions using histopathological images.
Dundar MM; Badve S; Bilgin G; Raykar V; Jain R; Sertel O; Gurcan MN
IEEE Trans Biomed Eng; 2011 Jul; 58(7):1977-84. PubMed ID: 21296703
[TBL] [Abstract][Full Text] [Related]
32. [Histopathological diagnosis of papillary lesion of the breast].
Akiyama F; Sakamoto G
Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():32-5. PubMed ID: 7747989
[TBL] [Abstract][Full Text] [Related]
33. Atypical ductal hyperplasia and ductal carcinoma in situ of the breast associated with perineural invasion.
Gobbi H; Jensen RA; Simpson JF; Olson SJ; Page DL
Hum Pathol; 2001 Aug; 32(8):785-90. PubMed ID: 11521220
[TBL] [Abstract][Full Text] [Related]
34. Is surgical excision necessary for focal atypical ductal hyperplasia found at stereotactic vacuum-assisted breast biopsy?
Eby PR; Ochsner JE; DeMartini WB; Allison KH; Peacock S; Lehman CD
Ann Surg Oncol; 2008 Nov; 15(11):3232-8. PubMed ID: 18696163
[TBL] [Abstract][Full Text] [Related]
35. Pathological criteria and practical issues in papillary lesions of the breast - a review.
Ni YB; Tse GM
Histopathology; 2016 Jan; 68(1):22-32. PubMed ID: 26768027
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic Reproducibility: What Happens When the Same Pathologist Interprets the Same Breast Biopsy Specimen at Two Points in Time?
Jackson SL; Frederick PD; Pepe MS; Nelson HD; Weaver DL; Allison KH; Carney PA; Geller BM; Tosteson AN; Onega T; Elmore JG
Ann Surg Oncol; 2017 May; 24(5):1234-1241. PubMed ID: 27913946
[TBL] [Abstract][Full Text] [Related]
37. Histopathologic analysis of atypical lesions in image-guided core breast biopsies.
Bonnett M; Wallis T; Rossmann M; Pernick NL; Bouwman D; Carolin KA; Visscher D
Mod Pathol; 2003 Feb; 16(2):154-60. PubMed ID: 12591968
[TBL] [Abstract][Full Text] [Related]
38. Can mammographic findings help discriminate between atypical ductal hyperplasia and ductal carcinoma in situ after needle core biopsy?
Hoang JK; Hill P; Cawson JN
Breast; 2008 Jun; 17(3):282-8. PubMed ID: 18063369
[TBL] [Abstract][Full Text] [Related]
39. Elucidating encounters of atypical ductal hyperplasia arising in gynaecomastia.
Wells JM; Liu Y; Ginter PS; Nguyen MT; Shin SJ
Histopathology; 2015 Feb; 66(3):398-408. PubMed ID: 25215584
[TBL] [Abstract][Full Text] [Related]
40. Why the term 'low-grade ductal carcinoma in situ' should be changed to 'borderline breast disease': diagnostic and clinical implications.
Masood S
Womens Health (Lond); 2012 Jan; 8(1):57-62. PubMed ID: 22171775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]